Flow cytometry confirmed the presence of an abnormal B-cell population consistent with B-cell chronic lymphocytic leukemia, with the following markers: CD19+, CD20+, CD23+, CD5+, CD10-. The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.